Margherita Ratti

Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O⁶-Methylguanine–DNA Methyltransferase–Silenced Metastatic Colorectal Cancer: The MAYA Trial

Federica Morano, Alessandra Raimondi, Filippo Pagani et al. · Journal of Clinical Oncology · 2022 · 120 citations · Full text

Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer

Joris van de Haar, Xuhui Ma, Salo Ooft et al. · Nature Medicine · 2023 · 74 citations · Full text

TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase II INFINITY Study

Alessandra Raimondi, Federica Palermo, Michele Prisciandaro et al. · Cancers · 2021 · 51 citations · Full text

Surgical Oncology, Esophageal Cancer, Immunology +20

Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: the CARACAS study

Sara Lonardi, Alessandra Anna Prete, Federica Morano et al. · Journal for ImmunoTherapy of Cancer · 2021 · 44 citations · Full text

Prognosis of elderly gastric cancer patients after surgery: a nomogram to predict survival

Michela Roberto, Andrea Botticelli, Lidia Strigari et al. · Medical Oncology · 2018 · 42 citations

Surgical Oncology, Geriatric Oncology, Gastrointestinal Oncology +11